Literature DB >> 9435310

Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection.

J Gong1, S Stenger, J A Zack, B E Jones, G C Bristol, R L Modlin, P J Morrissey, P F Barnes.   

Abstract

Because CD1-restricted T cells lack CD4 but produce IFN-gamma in response to nonpeptide mycobacterial antigens, they could play a unique role in immunity to tuberculosis. We studied CD1-restricted T cells in the context of HIV infection by expanding CD4(-) T cell lines from 10 HIV-infected patients. Upon stimulation with Mycobacterium tuberculosis antigen or upon exposure to macrophages infected with M. tuberculosis, these T cell lines proliferated, produced IFN-gamma, and showed cytolytic T cell (CTL) activity against macrophages pulsed with mycobacterial antigen, findings consistent with a protective role against M. tuberculosis. Anti-CD1b antibodies abrogated T cell proliferation, IFN-gamma production, and CTL activity, demonstrating that these T cells are CD1 restricted. IFN-gamma production in response to M. tuberculosis was enhanced by antitransforming growth factor-beta in 8/10 lines, and by IL-15 in 2/10 lines. IFN-gamma production was augmented in a nonantigen-specific manner by IL-12 in 4/8 lines. When live HIV was cocultured with CD1-restricted T cell lines, p24 antigen and proviral DNA were not detected, indicating that the T cells were not infectable with HIV. Vaccination strategies aimed at activation and expansion of M. tuberculosis-reactive CD1-restricted T cells in HIV-infected patients may constitute a novel means to provide protection against tuberculosis, while minimizing the risk of enhancing HIV replication through stimulation of CD4(+) cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435310      PMCID: PMC508577          DOI: 10.1172/JCI318

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

Authors:  E M Beckman; S A Porcelli; C T Morita; S M Behar; S T Furlong; M B Brenner
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

Review 2.  CD1 and the expanding universe of T cell antigens.

Authors:  S A Porcelli; R L Modlin
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

3.  Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis.

Authors:  Z Toossi; T G Young; L E Averill; B D Hamilton; H Shiratsuchi; J J Ellner
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

4.  CD1-restricted T cell recognition of microbial lipoglycan antigens.

Authors:  P A Sieling; D Chatterjee; S A Porcelli; T I Prigozy; R J Mazzaccaro; T Soriano; B R Bloom; M B Brenner; M Kronenberg; P J Brennan
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

5.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

6.  Accelerated course of human immunodeficiency virus infection after tuberculosis.

Authors:  C Whalen; C R Horsburgh; D Hom; C Lahart; M Simberkoff; J Ellner
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

7.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis.

Authors:  M Zhang; Y Lin; D V Iyer; J Gong; J S Abrams; P F Barnes
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

Authors:  S M Behar; S A Porcelli; E M Beckman; M B Brenner
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  10 in total

1.  HIV Disrupts Human T Cells That Target Mycobacterial Glycolipids.

Authors:  Victoria O Kasprowicz; Tan-Yun Cheng; Thumbi Ndung'u; Henry Sunpath; D Branch Moody; Anne G Kasmar
Journal:  J Infect Dis       Date:  2015-09-15       Impact factor: 5.226

2.  Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins.

Authors:  D M Russo; N Kozlova; D L Lakey; D Kernodle
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia.

Authors:  S M Smith; M R Klein; A S Malin; J Sillah; K Huygen; P Andersen; K P McAdam; H M Dockrell
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.

Authors:  A Giuliani; S P Prete; G Graziani; A Aquino; A Balduzzi; M Sugita; M B Brenner; E Iona; L Fattorini; G Orefici; S A Porcelli; E Bonmassar
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

6.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Authors:  Philippe H Lagrange; Satheesh K Thangaraj; Rajeshwar Dayal; Alaka Deshpande; Nirmal K Ganguly; Enrico Girardi; Beenu Joshi; Kiran Katoch; Vishwa M Katoch; Manoj Kumar; Vemu Lakshmi; Marc Leportier; Christophe Longuet; Subbalaxmi V S Malladi; Deepali Mukerjee; Deepthi Nair; Alamelu Raja; Balambal Raman; Camilla Rodrigues; Pratibha Sharma; Amit Singh; Sarman Singh; Archana Sodha; Basirudeen Syed Ahamed Kabeer; Guy Vernet; Delia Goletti
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 8.  Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity.

Authors:  Ulrich E Schaible; Lara Linnemann; Natalja Redinger; Emmanuel C Patin; Tobias Dallenga
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

9.  Induction of Mycobacterium Tuberculosis Lipid-Specific T Cell Responses by Pulmonary Delivery of Mycolic Acid-Loaded Polymeric Micellar Nanocarriers.

Authors:  Shaobin Shang; Dina Kats; Liang Cao; Eva Morgun; Diana Velluto; Ying He; Qichen Xu; Chyung-Ru Wang; Evan A Scott
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

10.  Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model.

Authors:  Jie Zhao; Sarah Siddiqui; Shaobin Shang; Yao Bian; Sreya Bagchi; Ying He; Chyung-Ru Wang
Journal:  Elife       Date:  2015-12-10       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.